Navigation Links
Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
Date:9/16/2008

ased in Jerusalem.

For more information, please visit http://www.oramed.com

Forward-looking statements

Some of the statements contained in this press release are forward-looking statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval for our product candidates; competition from other pharmaceutical or biotechnology companies; and the company's ability to obtain additional funding required to conduct its research, development and commercialization activities. Please refer to the company's filings with the Securities and Exchange Commission for a comprehensive list of risk factors that could cause actual results, performance or achievements of the company to differ materially from those expressed or implied in such forward looking statements. The company undertakes no obligation to update or revise any forward-looking statements.

Company and Investor Relation Contacts:

Oramed Pharmaceuticals

Eric Rosenberg

Cell: +972-54-566-7713

Office: +972-2-566-0001

Email: eric@oramed.com

Media Contacts:

Ruder Finn Israel for Oramed

Matthew Krieger

Cell: +972-54-467-6950

Office: +972-2-589-2003

Email: matthew@oramed.com


'/>"/>
SOURCE Oramed Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
2. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
3. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... -- In response to an FDA notice ... the Agency recommended that healthcare facilities discontinue use ... system, hospitals throughout the U.S. are faced with ... product. According to the FDA, STERIS made changes ... affect the safety or the effectiveness of the ...
(Date:12/14/2009)... directors of Eli Lilly and Company (NYSE: ... quarter of 2010 of $0.49 a share on outstanding ... March 10, 2010 to shareholders of record at the ... ,, Lilly, a leading innovation-driven corporation, is developing a ... research from its own worldwide laboratories and from collaborations ...
(Date:12/14/2009)... Dec. 14 Zargis Medical Corp., a ... ) and a spin-off from Siemens Corporate Research ... it has begun selling its award-winning Zargis Cardioscan(TM) ... Cardioscan and its accompanying Bluetooth®-enabled electronic stethoscope were ... "2009 Innovation of the Year." Cardioscan ...
Breaking Medicine Technology:ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 2ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 3Zargis Cardioscan 'The Intelligent Stethoscope' Now Available on Amazon.com 2WellNet Healthcare Names Chris Kaiser and Jay Thompson Sales Executives 49020 1WellNet Healthcare Names Chris Kaiser and Jay Thompson Sales Executives 49020 2Despite Generic Erosion of Key Brands the Hospital Acquired Gram Negative Infections Drug Market Will Increase by 241 Billion from 2008 to 2018 49015 1Despite Generic Erosion of Key Brands the Hospital Acquired Gram Negative Infections Drug Market Will Increase by 241 Billion from 2008 to 2018 49015 2Despite Generic Erosion of Key Brands the Hospital Acquired Gram Negative Infections Drug Market Will Increase by 241 Billion from 2008 to 2018 49015 3Broncus Technologies Exhale Stent and Other New Devices to Prompt Robust Growth In Emphysema Treatment Market According to Millennium Research Group 49010 1Broncus Technologies Exhale Stent and Other New Devices to Prompt Robust Growth In Emphysema Treatment Market According to Millennium Research Group 49010 2
... 6 Cadence Pharmaceuticals,Inc. (Nasdaq: CADX ), ... proprietary product candidates principally,for use in the hospital ... and nine months ended September 30, 2008., ... clinical development,programs for its two Phase III product ...
... SOUTH SAN FRANCISCO, Calif., Nov. 6 ... provide significant advances in cardiovascular and inflammatory,diseases, ... to betrixaban, the,company,s novel oral Factor Xa ... will be presented at the American Heart ...
Other Medicine Technology:Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 2Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 3Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 4Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 5Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 6Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 7Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update 8Portola Announces Data Presentations Relevant to Its Lead Phase II Antithrombotic Compounds at American Heart Association Scientific Sessions 2008 2
(Date:12/14/2009)... replaced tube watching , , MONDAY, Dec. 14 (HealthDay News) ... of television a week until he enrolled in a ... in half. , During his enforced period of deprivation, ... necessarily through strenuous exercise, although he did find his ... was spent reading and working on the computer, said ...
(Date:12/14/2009)... ,, NEW YORK, Dec. 14 /PRNewswire-USNewswire/ -- ... -- the largest survey on teen drug abuse tracking ... that teens, intentional abuse of prescription (Rx) and over-the-counter ... with an alarming number of young people abusing medicines ... Teen Abuse of Medication Continues to Be a ...
(Date:12/14/2009)... Krause, an aerospace engineer,for NASA, was giving the ... he,was confident that technology and science could solve ... one thing that science couldn,t solve.,His wife Susan ... machines,would keep her alive for awhile, she would ... 69 and is starting dialysis next month. She ...
(Date:12/14/2009)... scientists from the UC San Diego School of Medicine ... switch that helps prevent liver damage, including inflammation, fibrosis ... of how the protein, TAK1, works could lead to ... cancer. , "TAK1 appears to be a master ... professor of medicine and Dean of the UC San ...
(Date:12/14/2009)... meth and smoking, but concerns about prescription abuse, ... Fewer teenagers are using methamphetamine, but reductions in ... drugs remains high, U.S. health officials report. , ... as the hallucinogenic salvia leaf and the prescription ... attention-deficit hyperactivity disorder (ADHD), appear to be gaining ...
Breaking Medicine News(10 mins):Health News:Cutting TV Time Burns More Calories 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3Health News:Scientists uncover protective mechanism against liver cancer 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 4
... not to have sex until they get married is a ... for Sexual Health' meeting in Sydney. // ,William Smith, ... of the US, told delegates that a six-year study commissioned ... of dollars the government had spent on pushing sexual abstinence ...
... young woman, an Australian man gouged out both her eyes with ... the 28-year-old woman's partner, a man of around 30 years was ... ,The horrific string of events began with an ... Victorian country town- Malmsbury, 100 km northwest of Melbourne. This was ...
... the US have decided on raising tax on cigarettes and ... a deal agreed upon on Sunday, the state's cigarette tax ... expected additional flow to the treasury, of the order of ... programs. ,Most of the tax increase would be ...
... again. The Federal Drug Administration of U.S (FDA) has rejected its ... the market due to safety reasons. , The arthritis ... as Vioxx ,was voted out 20-1 by an advisory panel ... in September 2004 after research showed that it doubled the risk ...
... of successive Australian governments, a report commissioned by the ... lags an appalling one century behind that of the ... have significantly worse outcomes than their fellow countrymen on ... while inequality exists between Maori and non-Maori the gaps ...
... that chemotherapy patients complain about, is finally getting the ... have for years informed their doctors about cognitive symptoms ... difficulty retrieving words, trouble with multitasking and an overarching ... brushing such complaints aside, these very people, i.e. health ...
Other Medicine News:Health News:Smokers to Be Taxed to Fund Healthcare for Uninsured 2Health News:Arcoxia Slammed –Nothing Better Than Vioxx Says FD 2Health News:Aborigines Century Behind the Health of Colonizers, WHO Report 2Health News:Chemo Brain- Nothing Forgettable About It 2Health News:Chemo Brain- Nothing Forgettable About It 3
3.5v Standard Ophthalmoscope Set with Convertible Handle and Soft Case. Our Standard Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
High-quality eyecare from the preferred name in diagnostic instruments....
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Testing for Strabismus (ocular misalignment) just became easier. By simply placing the StrabismoScope over the patient's eye, the examiner is able to observe the occluded eye directly, but the patien...
Medicine Products: